Skip to content
Politically.com Search all
Menu

2026 · 3rd Quarter (July 1 - Sep 30)

PKD FOUNDATION

Filed by CURA STRATEGIES.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-10-31 06:26:15 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 20, 2026
Income
$10,000.00
Expenses
Not reported
Registrant
CURA STRATEGIES
Filing UUID
17d002ae-40ce-4332-aa2b-ac1773237fe0
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

Federal funding for PKD research at the National Institutes of Health (NIH).

HCR · Health Issues

Policies to relating to organ donation (H.R. 4583/4582 & S. 1552, the Living Donor Protection Act; H.R. 3698, the Living Organ Donor Tax Credit Act) and research into polycystic kidney disease (H.R. 9169, the PKD Cures Act).

Literal federal measure citations: H.R. 4583, S. 1552, H.R. 3698, H.R. 9169

DEF · Defense

Inclusion of PKD as a covered topic area under the Department of Defense's Peer Reviewed Medical Research Program (PRMRP).

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.